This article is free to access.
Chronic toxicities of locoregional and systemic oncological treatments commonly develop in long-term cancer survivors. Amongst these toxicities, post-radiotherapeutic complications alter patient's quality of life. Reduction of exposure of normal tissues can be achieved by optimization of radiotherapy. Furthermore, understanding of the fibrogenic mechanisms has provided targets to prevent, mitigate, and reverse late radiation-induced damages. This mini-review shows how (i) global molecular studies using gene profiling can provide tools to develop new intervention strategies and (ii) how successful clinical trials, conducted in particular with combined pentoxifylline-vitamin E, can take benefice of biological and molecular evidences to improve our understanding of fibrogenic mechanisms, enhance the robustness of proposed treatments, and lead ultimately to better treatments for patient's benefice. © 2012 Hamama et al; licensee BioMed Central Ltd.
Hamama, S., Delanian, S., Monceau, V., & Vozenin, M. C. (2012). Therapeutic management of intestinal fibrosis induced by radiation therapy: From molecular profiling to new intervention strategies et vice et versa. Fibrogenesis and Tissue Repair, 5(SUPPL.1). https://doi.org/10.1186/1755-1536-5-S1-S13